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Background: Functional loss of blood–brain barrier (BBB) is suggested to be pivotal to pathogenesis and pathology
of vascular-based neurodegenerative disorders such as Alzheimer’s disease. We recently reported in wild-type mice
maintained on standard diets, progressive deterioration of capillary function with aging concomitant with heightened
neuroinflammation. However, the mice used in this study were relatively young (12 months of age) and potential
mechanisms for loss of capillary integrity were not investigated per se. The current study therefore extended the
previous finding to investigate the effect of aging on BBB integrity in aged mice at 24 months and its potential
underlying molecular mechanisms.
Results: Immunomicroscopy analyses confirmed significantly increased capillary permeability with heightened
neuroinflammation in naturally aged 24-month old mice compared to young control at 3 months of age. Aged mice
showed significant attenuation in the expression of BBB tight junction proteins, occludin-1 and to lesser extent ZO-1
compared to young mice. In addition, TNF-α in cerebral endothelial cells of aged mice was significantly elevated
compared to controls and this was associated with heightened peripheral inflammation. The expression of ICAM-1 and
VCAM-1 remained unelevated, and no sign of leukocyte recruitment was observed in aged mice.
Conclusion: The BBB breakdown that occurs during ordinary aging is associated with inflammation and disruption of
tight junction complex assembly but not through leukocyte trafficking.
Keywords: Aging, Blood–brain barrier, Inflammation, Neurodegenerative disorder, Neuroinflammation, Leukocyte
infiltration, Tight junction complexBackground
The blood–brain barrier (BBB) is characterized with
tightly opposed endothelial cells and underlying basement
membranes to separate the central nervous system from
peripheral circulation. An accumulating body of evidence
suggests that disruption of BBB function followed by
blood-to-brain extravasation of circulating neuroinflam-
matory molecules may increase risk for the onset and* Correspondence: R.Takechi@curtin.edu.au
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unless otherwise stated.progress of cerebrovascular-based neurodegenerative dis-
orders such as Alzheimer’s disease (AD), vascular demen-
tia (VaD) and multiple sclerosis [1,2]. Consistent evidence
is provided in clinical and animal model studies where
cerebral extravasation of circulating proteins, perivascular
gliosis and lacunar lesions are commonly reported [1,3].
Aging is the most significant risk factor for vascular-
based neurodegenerative disorders, and in the US more
than 50% of population aged 80 years or older presents
with AD or VaD. Several studies have now shown that
the function and structure of BBB deteriorate during
aging and in the absence of comorbidities [4,5]. The
cerebrospinal fluid/serum ratio of albumin, a surrogatehis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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elevated with aging [6,7]. In addition, recent studies sug-
gest that increased BBB permeability in aged rodent
brains is associated with reduced expression of BBB tight
junction proteins [8,9]. Our previous study showed that
in mid-aged 12 months old wild-type C57BL/6 J mice,
increased cerebrocapillary permeability was shown to be
associated with heightened neuroinflammation, however
mechanisms involved in BBB disruption were not ex-
plored [10].
Disrupted tight junctional complex assemblies and ac-
tive leukocyte trafficking may be central to cerebral ca-
pillary function. Assembly of BBB junctional complexes
may be regulated by inflammatory pathways. In vitro
and in vivo studies demonstrated that pro-inflammatory
cytokines including TNF-α and IL-1β regulates the ex-
pression of tight junction proteins occludin-1, claudin-5,
ZO-1 and ZO-2 [11-15]. Leukocyte trafficking and re-
cruitment is a process that describes the paracellular
transmigration of circulating leukocytes through the vas-
cular wall into perivascular space of the brain [16]. In-
creased expression of adhesion molecules such as
vascular cell adhesion molecules (VCAM-1) and inter-
cellular adhesion molecules (ICAM-1) are reported to
initiate this process by promoting leukocyte rolling and
firm adhesion to BBB endothelial cell surface [17,18].
Studies also demonstrate that TNF-α upregulates the ex-
pression of ICAM-1 and VCAM-1 [19]. However, in-
volvement of these pathways in aging induced BBB
dysfunction has not been reported in naturally aged
wild-type mice.
This study explored capillary integrity, inflammation
and the expression of proteins central to leukocyte re-
cruitment in very aged 24-month old C57BL/6 J.
Results
The mice aged to 24 months were otherwise healthy and
had no adverse event recorded. The extravasation of cir-
culating IgG into cerebral parenchyme was significantly
increased in the cortex and hippocampal formation of
aged mice compared to young control mice (Figure 1A).
Significantly elevated neurovascular inflammation and
neuronal stress were also indicated with increased ex-
pression of GFAP, GRP78 and COX-2 in 24 months old
mice (Figure 1B).
The analyses with flow cytometry showed that expres-
sion of BBB tight junction protein occludin-1 was sig-
nificantly attenuated in aged mice compared to control,
while the expression of ZO-1 was modestly decreased in
aged rats (Figure 2A, B). No significant increase in endo-
thelial expression of ICAM-1 was observed and VCAM-1
was decreased in aged mice compared to young control
(Figure 2C). Perivascular immunomicroscopy analysis
showed no sign of circulating leukocyte transmigration inentire cortex and hippocampal formation of aged mice,
and representative images are shown in Figure 2D. Flow
cytometry of the whole brain also showed that less than
1% of total cells were CD45 positive regardless of age, and
no significant difference between young vs aged mice was
observed (data not shown).
The BBB endothelial concentration of TNF-α was sig-
nificantly increased in aged mice compared to young
mice, whereas no change was seen in the intracellular
level of IL-1β (Figure 3A, B). Pearson’s correlation coeffi-
cient analysis showed that endothelial levels of TNF-α
were negatively correlated with BBB occludin-1 expres-
sion (p = 0.04), whilst a weaker negative correlation was
found with ZO-1 (p = 0.75) (Figure 3C). The cytometric
bead array showed significantly heightened IL-6 in aged
mice (6.38 ± 2.28 pg/mL) compared to young control mice
(0.57 ± 0.31 pg/mL), whereas the levels of other pro-
inflammatory cytokines, IL-10, IL-12, TNF-α and IFN-γ,
remained comparable between young control and aged
mice (data not shown). Pearson’s correlation analysis
showed positive correlation coefficient between the periph-
eral IL-6 and endothelial TNF-α (p = 0.002) (Figure 3D).
Discussion
A functional consequence of increased cerebral capillary
permeability with aging is enhanced blood-to-brain de-
livery of circulating neuroinflammatory molecules. Dis-
turbed BBB has been reported in mid-aged rodent
models independent of co-morbidities or the provision
of pro-inflammatory diets. The mechanisms for the
aging-induced effects on capillary function are not yet
delineated. The present study extended previous studies
and investigated in very aged mice, whether inflamma-
tion and/or leukocyte recruitment are associated with
loss of tight junction proteins.
Consistent with previous findings, semi-quantitative
immunomicroscopy analyses confirmed aging-induced
BBB dysfunction with substantially increased parenchy-
mal abundance of IgG in 24 months old wild-type mice
compared to 3 months old young control. Increased
cerebral expression of GFAP showed significantly in-
creased astrocytosis and astrogliosis in the cerebral peri-
vascular parenchyme and cerebrovascular astrocytic end
feet of naturally aged mice compared to young control.
In addition, significantly elevated immunoreactivity of
GRP78 and COX-2 mainly in the perinuclear region of
neuronal cells demonstrated substantial cellular ER
stress and inflammation in the aged mice. The findings
are consistent with the notion that BBB dysfunction with
aging may increase risk for vascular-based neurodegen-
erative disorders.
Only several studies have investigated potential mech-
anisms involved in BBB breakdown with normal aging
and these suggest heightened inflammatory processes
Figure 1 (See legend on next page.)
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Figure 1 Blood–brain barrier integrity and neuroinflammation. (A) The integrity of BBB was assessed by measuring the blood-to-brain
extravasation of IgG with semi-quantitative confocal microscopy in the cortex (CTX) and hippocampal formation (HPF) of 3 months old young mice
and 24 months old aged mice. The voxel intensity of protein of interest is expressed as per volume unit. Asterisks indicate statistical significance
assessed with two-tailed t-test (p < 0.05, n = 6). Representative immunomicrographs are also shown (green = IgG, blue = DAPI, scale bar = 20 μm).
(B) The astroglial activation, neuronal ER stress and inflammation were assessed by measuring the expression of GFAP, GRP78 and COX-2 respectively.
Representative immunomicrographs are shown (yellow= GFAP, red = GRP78, magenta = COX-2, blue = DAPI, scale bar = 50 μm).
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tiates the permeability of BBB by suppressing the ex-
pression of tight junction complexes [11,12,21], whilst
inhibition of TNF-α, or treatment with anti-results in
restoration of the tight junction protein expression and
normalized BBB integrity [13]. Similarly, anti-TNF-α
antibodies were shown to attenuate BBB permeability via
restored expression of BBB tight junction proteins in rat
model of acute liver failure [22]. In this study, exagger-
ated endothelial TNF-α in aged mice was associated with
reduced expression of the BBB tight junction proteins,
occludin-1 and ZO-1. In addition to the effects on tight
junction protein expression, Previous in vitro studies
showed TNF-α significantly increases the expression of
BBB endothelial ICAM-1 and VCAM-1, which can fa-
cilitate the adhesion and transmigration of leukocytes
across BBB [18]. In the very aged mice studied, there
was no evidence of increased adhesion molecule expres-
sions and leukocyte infiltration across BBB. Supporting
data is presented by Miguel-Hidalgo et al. showing that
in human 60–86 years old orbitofrontal cortex, the cere-
brovascular expression of ICAM-1 remained unchanged
compared to younger brain (27–54 years old) [23].
A number of studies reported that chronically elevated
pro-inflammatory cytokines including TNF-α, IL-1β and
IL-6 in the periphery occurs with normal aging [24,25].
When BBB endothelial cells are exposed to chronically
heightened peripheral circulating inflammatory cyto-
kines, expression of NF-κB subunits becomes signifi-
cantly exaggerated [12]. NF-κB is one of the major
transcription factors for inflammatory responses and
triggers the secretion of pro-inflammatory cytokines in-
cluding TNF-α and IL-1β. Elevated NF-κB expression
and activity are also reported to promote cerebrovascular
endothelial leukocyte infiltration by up-regulating expres-
sion of adhesion molecules through elevated inflammatory
cytokines [26-28]. Similarly, augmentation of NF-κB sub-
units is involved in the suppression of tight junction pro-
teins including occludin-1, claudin-5, ZO-1 and JAM-1 of
BBB through increased pro-inflammatory cytokines [29].
IL-1β can induce the degradation of tight junction pro-
teins including claudin-5, ZO-1 and ZO-2 [14,15,30] and
treatment with anti-IL-1β antibody suppressed the exag-
gerated BBB permeability of in vitro endothelial mono-
layer model exposed to hypoxia [31,32]. Consistent withthe potential detrimental effects of increased vascular ex-
posure with aging to cytokines on capillary function, the
concentration of IL-6 in the peripheral circulation was sig-
nificantly increased and positively correlated with the
cerebrovascular endothelial TNF-α in 24-month old wild
type mice of present study.
Collectively, the findings of this study suggest that the
mechanisms of BBB dysfunction that occurs in normal
aging may result from the loss of endothelial tight junc-
tions, induced by pro-inflammatory TNF-α through
heightened peripheral inflammation, but not from leu-
kocyte recruitment mediated by endothelial adhesion mol-
ecules. BBB leukocyte infiltration may more likely be
involved in the pathological state of BBB dysfunction. The
outcomes of this study offer an insight into the mecha-
nisms involved in capillary dysfunction with normal aging.
In the present study, the ageing effect was only consid-
ered in female mice. Studies report that male mice are
more vulnerable to aging related changes of capillary in-
tegrity, possibly because of andogenic hormone effects
[33]. Further studies to investigate potential gender dif-
ferences are appropriate. Nonetheless, the broader find-
ings of this study suggest that disturbance in capillary




Six female wild-type C57BL/6 J mice were purchased
from Animal Resources Centre (WA, Australia). Mice
were maintained at Curtin University Animal Facility
until 24 months of age with 12 h light/dark cycle, ad
libitum access to standard chow and water. Only
healthy, disease free mice were used in this study. As a
young control group, 6 mice at age of 3 months were
also purchased from Animal Resources Centre at the
time of sacrifice. All mice were anesthetized with isoflor-
ane and killed with cervical dislocation. Plasma samples
were collected and stored at −80°C. The right hemi-
sphere of the brain tissue was carefully removed, fixed in
4% paraformaldehyde for 24 h, and frozen in isopen-
tane/dry ice for immunohistochemistry staining. The left
brain hemisphere was collected in FACs buffer (2% FBS,
1% BSA in PBS) with 10 μg/ml brefeldin (Sigma-Aldrich)
for flow cytometry analysis. All animal procedures
Figure 2 (See legend on next page.)
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Figure 2 Cerebrovascular tight junction proteins and leukocyte recruitment. BBB tight junction assembly was assessed by measuring
endothelial cell expressions of occludin-1 and ZO-1 with flow cytometry in the brains of 3 months old young mice and 24 months old aged mice.
Example plots are in (A) and the fluorescent intensity of protein of interest is expressed as per endothelial cell (B). Asterisks indicate statistical
significance assessed with two-tailed t-test (p < 0.05, n = 6). (C) Endothelial expression of adhesion proteins, ICAM-1 and VCAM-1, was measured
with flow cytometry. (D) The infiltration of leukocytes across the BBB was assessed with immunomicroscopy staining of CD45 immunoreactivity
within the perivascular region of entire cortex and hippocampal formation. Representative images are shown. Scale bar indicates 20 μm.
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Health and Medical Research Council of Australia ap-
proved Animal Ethics Committee (Curtin University, ap-
proval no. AEC_2012_21).
Three-dimensional semi-quantitative immunomicroscopy
for parenchymal IgG extravasation
The BBB integrity was considered by measuring the par-
enchymal abundance of, IgG using semi-quantitative con-
focal immunomicroscopy as described previously [34-36].
Briefly, after blocking with 10% goat serum, 20 μm cryo-
sections were incubated with goat anti-mouse IgG con-
jugated with Alexa488 (1:50, LifeTechnologies) for 20 h at
4°C. The sections were counterstained with DAPI. A mini-
mum of eight and five 3-D images were captured ran-
domly from the cortex and hippocampal formation region
of the brain section, respectively with UltraVIEW Vox
spinning disc confocal microscope (PerkinElmer). Total
image area captured and quantified represented approxi-
mately 60% of the hippocampal formation and cortex. The
voxel intensity of fluorescence of each 3-D image was ana-
lyzed with Volocity imaging software (PerkinElmer), and
averaged within each region by using all eight or five 3-D
images to estimate the representative voxel intensity per
region per mouse. Then the mean voxel intensity of IgG
extravasation was calculated within each treatment group
(n = 6). The parenchymal staining of IgG was specifically
selected and staining within the blood vessels were ex-
cluded based on pre-set threshold parameters of Volocity
and thereafter confirmed for each image to ensure proper
selection by identifying the nucleus of BBB endothelial
cells.
Three-dimensional semi-quantitative immunomicroscopy
for neuroinflammatory and stress markers and leukocyte
infiltration
The markers of neuroinflammation and neuronal stress,
glial fibrillary acidic protein (GFAP), cyclooxygenase-2
(COX-2) and 78 kDa glucose-regulated protein (GRP78)
were measured with immunomicroscopy as described
previously [10,37,38]. Briefly, 20 μm cryosections were
incubated with either rabbit anti-mouse GFAP, GRP78,
or COX-2 (1:200, 1:1000 or 1:200, respectively, Abcam)
for 20 h at 4°C. The sections were then incubated with
goat anti-rabbit IgG conjugated with Alexa488 (1:200,LifeTechnologies) for 2 h at 20°C. Nuclei were counter-
stained with DAPI and the fluorescent staining was ob-
served with UltraVIEW Vox microscope. Similar to IgG
extravasation, voxel intensity of the protein of interest
was determined with Volocity from at least eight and
five randomly captured 3-D images in the cortex and
hippocampus, respectively.
The BBB infiltration of leukocyte was assessed with
immunomicroscopy detection of anti-CD45 immunore-
activity within the perivascular region of entire cortex
and hippocampus for all mice. 20 μm cryosections were
incubated with anti-CD45 conjugated with PerCP-Cy5.5
for 20 h at 4°C, and the fluorescent staining was ob-
served with UltraVIEW Vox microscope.
Flow cytometry analysis of endothelial tight junction
protein, inflammatory cytokine and adhesion molecules,
and cerebral leukocytes
The expression of cerebrovascular endothelial tight junc-
tion occludin-1 and ZO-1, pro-inflammatory TNF-α and
IL-1β, and adhesion VCAM-1 and ICAM-1 was mea-
sured by flow cytometry as established previously with
some modifications [39-41]. The left hemisphere of the
brain was sliced into 0.5 mm3 fractions in FACs buffer
with 10 μg/ml brefeldin. The tissue was then digested
with 1 mg/ml collagenase IV (Sigma-Aldrich), 1 mg/ml dis-
pase (Sigma-Aldrich), and 1 mg/ml DNase (Sigma-Aldrich)
in FACs buffer with 2.5 μg/ml brefeldin at 37°C for
30 min. Samples were then triturated to obtain a single
cell suspension and the cells were incubated with FACs
buffer containing 20% FBS and 2.5 μg/ml brefeldin for
10 min at 4°C.
Cell suspensions were incubated with fluorescently
labeled antibodies against extracellular markers: anti-CD45-
PerCP-Cy5.5 (1:500, Biolegend, cat#: 103132), anti-CD31-
BV421 (1:200, Biolegend, cat#: 102423), anti-VCAM-1-APC
(1:200, Biolegend, cat#: 105718), and anti-ICAM-1-PE
(1:200, Biolegend, cat#: 116108). For intracellular staining,
cells were fixed in 1% paraformaldehyde (Sigma-Aldrich)
and permeabilised with 0.1% saponin (Sigma-Aldrich) for
15 min at 4°C. The cells were then incubated with anti-
bodies against intracellular markers: rabbit anti-occludin-1
unconjugated (1:50, Abcam, cat #:ab167161), anti-TNF-α-
APC (1:50, Biolegend, cat: 506308), anti-IL-1β-PE (1:50,
eBioscience, cat#: 12-7114-82) or rabbit anti-ZO-1
Figure 3 Blood–brain barrier endothelial levels of pro-inflammatory cytokines. The intracellular levels of TNF-α and IL-1β in cerebrovascular
endothelial cells were measured with flow cytometry in the brains of 3 months old young mice and 24 months old aged mice. Example plots in
(A) and mean of n = 6 in (B). Asterisks indicate statistical significance assessed with two-tailed t-test (p < 0.05, n = 6). (C) The causal association of
attenuated BBB tight junction proteins, occludin-1 or ZO-1, with endothelial TNF-α was analyzed with Pearson’s correlation coefficient (n = 12).
(D) The association between the cerebrovascular TNF-α and peripheral IL-6 was determined with Pearson’s correlation coefficient (n = 12).
Elahy et al. Immunity & Ageing  (2015) 12:2 Page 7 of 9unconjugated (1:100, Abcam, cat #:ab59720) for 30 min at
4°C. Subsequently the cells were incubated with anti-
rabbit IgG Alexa488 (1:500) for 30 min at 4°C, and washed
with FACs buffer.Samples were acquired on a FACS Canto II (BD Bio-
sciences). Cells were first gated so that only viable, single
cells were analyzed and cerebrovascular endothelial cells
were then identified as CD31 positive CD45 negative. To
Elahy et al. Immunity & Ageing  (2015) 12:2 Page 8 of 9validate the staining and account for any potential differ-
ences between the young and aged endothelial cells, in-
cluding autofluorescence, a combination of isotype
controls and other internal staining controls were used
(example gating shown in Additional file 1: Figure S1).
The fluorescent intensity of occludin-1, ZO-1, TNF-α, IL-
1β, VCAM-1 and ICAM-1 was analyzed with FlowJo V10
software (Treestar) and expressed per endothelial cell.Plasma levels of inflammatory cytokines
Plasma concentrations of IL-6, IL-10, IL-12, TNF-α, IFN-c
and MCP-1 were determined using the mouse inflamma-
tion cytokine bead assay (BD Biosciences) according to
the manufacturer’s instruction. Briefly, samples (diluted 1
in 2 in assay buffer) and standards were incubated with
fluorescently labeled capture and detection beads for
2 hrs. Following washing, samples and standards were ac-
quired on a FACS Canto II. Analysis was performed using
FlowJo V10 software and sample concentration calculated
from the standard curve generated for each cytokine using
GraphPad Prism.Statistical analysis
Each young control and aged group had 6 mice to provide
sufficient power to compare the effect of Aging on BBB
function and structure which was determined based on
previous studies where BBB function was analysed with
same or similar methods and models [35,42,43]. The
present study was analysed using Mice similar to “blocks”
within the student t-test. Hence individual measurements
have been adjusted for the Mice or “block” effect, which
was essentially used as a covariate. Student t-test was used
to determine the statistical significance between control
and aged group (p < 0.05). Pearson’s correlation coeffi-
cient analysis was used with pooled data of both control
and aged group to determine significant associations (n = 12,
p < 0.05).Additional file
Additional file 1: Figure S1. Gating strategy for brain endothelial cells.
Brains from young (2 months) or aged (24 months) C57BL/6 J mice were
collected for flow cytometric analysis. After gating on single cells,
endothelial cells were identified as CD45negCD31+ cells. Boundaries for
the gating selection were determined using fluorescence minus one
controls and representative plots are shown.Competing interests
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